Genetic and Physical Study of Childhood Nerve and Muscle Disorders
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/2/2019 |
| Start Date: | March 14, 2012 |
| Contact: | Sandra Donkervoort |
| Email: | sandra.donkervoort@nih.gov |
| Phone: | (301) 496-0272 |
Clinical and Molecular Manifestations of Neuromuscular and Neurogenetic Disorders of Childhood
Background:
- Some nerve and muscle disorders that start early in life (before age 25), like some forms
of muscular dystrophy, can run in families. However, the genetic causes of these disorders
are not known. Also, doctors do not fully understand how symptoms of these disorders change
over time. Researchers want to learn more about genetic nerve and muscle disorders that start
in childhood by studying affected people and their family members, as well as healthy
volunteers.
Objectives:
- To better understand nerve and muscle disorders that start early in life and run in
families.
Eligibility:
- Individuals at least 4 weeks old with childhood-onset muscular and nerve disorders,
including those who have a later onset of a disorder that typically has childhood onset.
- Affected and unaffected family members of the individuals with muscular and nerve
disorders.
- Healthy volunteers at least 4 weeks old with no nerve or muscle disorders.
Design:
- Participants will be screened with a physical exam and medical history. Genetic
information will be collected from blood, saliva, cheek swab, or skin samples. Urine
samples may also be collected.
- Healthy volunteers and unaffected family members will have imaging studies of the
muscles. These studies will include magnetic resonance imaging (MRI) and ultrasound
scans. Results will be compared with those from the affected participants.
- All participants with nerve and muscle disorders will have multiple tests, including the
following:
- Imaging studies of the muscles, including ultrasound and MRI scans.
- Imaging studies of the bones, such as x-rays and DEXA scans.
- Heart and lung function tests.
- Eye exams.
- Nerve and muscle electrical activity tests and biopsies.
- Video and photo image collection of affected muscles.
- Speech, language, and swallowing evaluation.
- Lumbar puncture to collect spinal fluid for study.
- Tests of movement, attention, thinking, and coordination.
- Participants with nerve and muscle disorders will return to the Clinical Center every
year. They will repeat the tests and studies at these visits.
- Some nerve and muscle disorders that start early in life (before age 25), like some forms
of muscular dystrophy, can run in families. However, the genetic causes of these disorders
are not known. Also, doctors do not fully understand how symptoms of these disorders change
over time. Researchers want to learn more about genetic nerve and muscle disorders that start
in childhood by studying affected people and their family members, as well as healthy
volunteers.
Objectives:
- To better understand nerve and muscle disorders that start early in life and run in
families.
Eligibility:
- Individuals at least 4 weeks old with childhood-onset muscular and nerve disorders,
including those who have a later onset of a disorder that typically has childhood onset.
- Affected and unaffected family members of the individuals with muscular and nerve
disorders.
- Healthy volunteers at least 4 weeks old with no nerve or muscle disorders.
Design:
- Participants will be screened with a physical exam and medical history. Genetic
information will be collected from blood, saliva, cheek swab, or skin samples. Urine
samples may also be collected.
- Healthy volunteers and unaffected family members will have imaging studies of the
muscles. These studies will include magnetic resonance imaging (MRI) and ultrasound
scans. Results will be compared with those from the affected participants.
- All participants with nerve and muscle disorders will have multiple tests, including the
following:
- Imaging studies of the muscles, including ultrasound and MRI scans.
- Imaging studies of the bones, such as x-rays and DEXA scans.
- Heart and lung function tests.
- Eye exams.
- Nerve and muscle electrical activity tests and biopsies.
- Video and photo image collection of affected muscles.
- Speech, language, and swallowing evaluation.
- Lumbar puncture to collect spinal fluid for study.
- Tests of movement, attention, thinking, and coordination.
- Participants with nerve and muscle disorders will return to the Clinical Center every
year. They will repeat the tests and studies at these visits.
Objective:
To diagnose and elucidate the underlying disease mechanism in patients with neuromuscular and
neurogenetic disorders with congenital or pediatric onset (phase 1 of the protocol) and to
study the natural history and mechanism of disease in neuromuscular and neurogenetic
disorders of childhood (phase 2 of the protocol).
Study population:
Patients with childhood onset neuromuscular and neurogenetic disorders, their affected and
unaffected family members, and healthy volunteers. Patients with later onset of a disorder
that is known to typically have childhood onset will be included as well.
Design:
Diagnostic and prospective longitudinal natural history study.
Outcome Measures:
Diagnose and characterize patients with neuromuscular and neurogenetic disorders with
congenital or pediatric onset and study the natural history and underlying disease mechanism.
In the characterized patient population identify and develop effective outcome measures for
use in future clinical trials, including applicable motor scales, quality of life scales,
biomarkers from blood and urine, imaging studies, and pulmonary function tests.
To diagnose and elucidate the underlying disease mechanism in patients with neuromuscular and
neurogenetic disorders with congenital or pediatric onset (phase 1 of the protocol) and to
study the natural history and mechanism of disease in neuromuscular and neurogenetic
disorders of childhood (phase 2 of the protocol).
Study population:
Patients with childhood onset neuromuscular and neurogenetic disorders, their affected and
unaffected family members, and healthy volunteers. Patients with later onset of a disorder
that is known to typically have childhood onset will be included as well.
Design:
Diagnostic and prospective longitudinal natural history study.
Outcome Measures:
Diagnose and characterize patients with neuromuscular and neurogenetic disorders with
congenital or pediatric onset and study the natural history and underlying disease mechanism.
In the characterized patient population identify and develop effective outcome measures for
use in future clinical trials, including applicable motor scales, quality of life scales,
biomarkers from blood and urine, imaging studies, and pulmonary function tests.
- INCLUSION AND EXCLUSION CRITERIA:
Probands inclusion criteria Phase 1:
1. Aged 4 weeks and older
2. Documentation of a personal history of a childhood-onset, hereditary/familial,
neurological disorder or later onset of a disease that more commonly has childhood
onset. Acceptable documentation includes evaluation through any or all of the
following evaluations done prior to enrollment.
1. Medical history, including family history information
2. Physical examination
3. Muscle, nerve, or skin biopsy
4. Magnetic resonance imaging (MRI)
5. Electromyography (EMG)
6. Nerve conduction study (NCS)
7. Electroencephalogram (EEG)
8. Muscle ultrasound
9. Genetic, metabolic, or other laboratory testing such as increased serum Creatine
Kinase (CK) and abnormal serum lactate/pyruvate ratio.
Probands inclusion criteria Phase 2:
1. Aged 4 weeks and older
2. Documentation of a defined childhood onset neuromuscular and neurogenetic disorders
through phase 1 testing.
Exclusion criteria for probands Phase 1:
1. Individuals who are unable or unwilling to be examined.
2. Minors who do not have a parent or guardian able to provide informed consent.
3. Adults seen offsite who are unable to provide their own consent.
Exclusion criteria for probands Phase 2:
1. Individuals who are unable or unwilling to be examined.
2. Adults who are unable to provide their own consent and who have not previously
appointed an individual with Durable Power of Attorney (DPA) or who are unable to
appoint a DPA or guardian.
3. Minors who do not have a parent or guardian able to provide informed consent.
4. Adults seen offsite who are unable to provide their own consent.
Unaffected Family members - Inclusion Criteria:
1. Unaffected family members must be related by blood to a proband enrolled in the study.
Biological relations may include first (parent or sibling), second (grandparents,
aunts, uncles, half siblings) and third degree relatives (cousins).
2. Age 4 weeks and older.
Unaffected Family members - Exclusion Criteria:
1. Individuals whom are unable or unwilling to be examined.
2. Family members who are showing symptoms of the familial neurogenetic or neuromuscular
condition (these may be enrolled as probands).
3. Neonates.
4. Adults who are unable to provide their own consent.
Healthy Volunteers - Inclusion Criteria:
1. Must be unaffected by a neurological condition.
2. Willing and able to comply with all protocol requirements and procedures, including
MRI without sedation and without contrast.
3. Able to give informed assent and parent(s)/legal guardian to give informed consent in
writing signed by the subject and/or parent(s)/legal guardian.
Healthy Volunteers - Exclusion Criteria:
1. Healthy volunteers who have metal objects in their body that are not MRI-safe. These
include the following objects: 1) pacemakers or other implanted electrical devices; 2)
brain stimulators; 3) some types of dental implants; 4) aneurysm clips (metal clips on
the wall of a large artery); 5) metallic prostheses (including metal pins and rods,
heart valves, and cochlear implants; 6) implanted delivery pump; 7) permanent eye
liner; or 8) shrapnel fragments.
2. Healthy volunteers who have a fear of closed spaces.
3. Neonates.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials
